Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
Clinical trial NCT06173531 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06173531
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-27
- Primary completion
- 2025-10-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.